PET/CT imaging in different types of lung cancer: an overview |
| |
Authors: | Ambrosini Valentina Nicolini Silvia Caroli Paola Nanni Cristina Massaro Arianna Marzola Maria Cristina Rubello Domenico Fanti Stefano |
| |
Institution: | Department of Nuclear Medicine, Sant' Orsola-Malpighi Hospital, Bologna, Italy. |
| |
Abstract: | Lung cancer (LC) still represents one of the most common tumours in both women and men. PET/CT is a whole-body non-invasive imaging procedure that has been increasingly used for the assessment of LC patients. In particular, PET/CT added value to CT is mainly related to a more accurate staging of nodal and metastatic sites and to the evaluation of the response to therapy. Although the most common PET tracer for LC evaluation is 18F-FDG, new tracers have been proposed for the evaluation of lung neuroendocrine tumours (68Ga-DOTA-peptides, 18F-DOPA) and for the assessment of central nervous system metastasis (11C-methionine). This review focuses on the main clinical applications and accuracy of PET/CT for the detection of non-small cells lung cancer (NSCLC), broncho-alveolar carcinoma (BAC), small cells lung cancer (SCLC), lung neuroendocrine tumours (NET) and solitary pulmonary nodules (SPN). |
| |
Keywords: | Lung cancer Various types PET/CT 18F-FDG 18F-DOPA 68Ga-DOTA-peptides Indications Drawbacks |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|